KYTRIL, generically known as granisetron, is a potent antiemetic medication primarily used to prevent nausea and vomiting caused by cancer chemotherapy and radiation therapy. It belongs to a class of drugs known as serotonin 5-HT3 receptor antagonists. By blocking the action of serotonin, a natural substance in the body that can cause vomiting, KYTRIL effectively manages and controls the side effects associated with cancer treatments. It is available in various forms, including tablets, oral solution, and injectable form, making it versatile for different patient needs. KYTRIL is known for its efficacy in improving the quality of life for patients undergoing cancer therapy by mitigating one of the most uncomfortable and distressing side effects of such treatments.